drugset / Trial / NCT02632331

ASP8825 - A Study to Investigate the Food Effect on the Pharmacokinetics of ASP8825

NCT02632331

Phase 1 Completed 18 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of this study is to evaluate the effect of food on the pharmacokinetics and safety after administration of ASP8825 in healthy non-elderly adult male subjects.

Timeline

Start
2009-01
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject gabapentin enacarbil Small molecule Oral

Indications

No indication recorded.